Skip secondary menu

NINDS Neuroscience Funding Announcements



Preclinical Development Facility CINAPS Drug Optimization Program Request for Information (RFI)

Funding Contact(s): Helene Braun
Funding Categories: Neurodegeneration

Brief Description:

The National Institute of Neurological Disorders and Stroke (NINDS) is exploring the market interest and capabilities relating to the development of a contract facility with the ability to conduct preclinical animal drug studies in different models of Parkinson's Disease. The contract facility would have 3 functions: 1) conduct efficacy and pharmacokinetic studies in a range of rodent models of Parkinson's disease; 2) conduct some toxicology studies; 3) provide research support for the neuroprotection drug selection process (CINAPS), such as literature reviews and assembling drug dossiers.



NIH Guide: NOT-NS-05-008
Release Date: 2005-04-20
Expiration Date: 2005-05-19